MedPath

Magnesium in health and disease states.

Not Applicable
Conditions
Health Condition 1: I251- Atherosclerotic heart disease of native coronary arteryHealth Condition 2: I10- Essential (primary) hypertensionHealth Condition 3: E785- Hyperlipidemia, unspecifiedHealth Condition 4: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2018/12/016746
Lead Sponsor
Manipal Academy of Higher Education
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with Type 2 DM, HTN, Dyslipidemia and CAD

and in the age group of 40 to 79 yrs

Exclusion Criteria

Patients who are having chronic kidney disease, chronic liver disease, endocrinopathy, rheumatologic diseases, magnesium supplements, antacids, diuretics and chronic alcoholic will be excluded.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome expected in this study would be whether low magnesium levels in blood is associated with Type 2 Diabetes Mellitus, Hypertension, Dyslipidemia and Coronary artery disease and its correlation with ASCVD risk score. Hence there may be a role of magnesium supplementation in preventing these diseases.Timepoint: Day 1
Secondary Outcome Measures
NameTimeMethod
Magnesium levels in only diabetics, magnesium levels in diabetes with hypertension, magnesium levels in diabetes with hypertension and dyslipidemia.Timepoint: Day 1
© Copyright 2025. All Rights Reserved by MedPath